Illuccix® Approved for Prostate Cancer Imaging in Brazil: First Marketing Authorization in Latin America
MELBOURNE, Australia and PORTO ALEGRE, Brazil, March 18, 2025 /PRNewswire/ -- Telix Pharmaceuticals Limited (ASX: TLX, Nasdaq: TLX, Telix, the Company) today announces that the Brazilian Health Regulatory Agency (Agencia Nacional de Vigilancia...
FinVolution Group Announces New Share Repurchase Program Up To US$150 million
SHANGHAI, March 18, 2025 /PRNewswire/ -- FinVolution Group ("FinVolution," or the "Company") (NYSE: FINV), a leading fintech platform in China, Indonesia and the Philippines, today announced that the board of directors of the Company (the "Board")...
Essential Energy Selects Oracle to Modernise NSW's Largest Electricity Network
Leading energy distributor achieves core-to-edge modernisation with Oracle's finance, HR, and workforce solutions to improve efficiency, support renewables, and enhance customer services SYDNEY, March 18, 2025 /PRNewswire/ -- Oracle CloudWorld Tour...
Outline Global Develops AI-Enabled Geospatial Mapping Platform with Oracle Database 23ai
Melbourne-based aerial intelligence firm leverages Oracle AI Vector Search to deliver data-intensive geospatial insights for its Australian clients. Harnesses the power of AI to increase revenue by 30 percent and grow lead generation pipeline by 50...
FinVolution Group Reports Fourth Quarter and Fiscal Year 2024 Unaudited Financial Results
-Full Year 2024 Transaction Volume reached RMB206.2 billion, up 6.1% year-over-year- -Full Year 2024 International Transaction Volume exceeded RMB10.1 billion, up 27.8% year-over-year- -Full Year International Revenues reached RMB2.5 billion, up...
TaiMed Biologics Announces Results from Late-Breaking Phase 2a Data on Long-Acting HIV Maintenance Therapy at CROI 2025
TMB-365/TMB-380 Combination Demonstrates Viral Suspension Without the Need for Susceptibility Screening TaiMed Biologics will reshape HIV treatment management and seeks strategic collaborations with global pharmaceutical partners for the...
Health In Tech Announces Fourth Quarter and Full Year 2024 Financial Results
Total audited revenue for 2024 was $19.5 million. The first two months of 2025, our unaudited revenue is about $5.7million, more than 50% growth year over year for the first two months of 2024, and exceeded the revenue of the entire Q1 of 2024 Cash...
Health in Tech Expands Executive Team to Drive Growth and Innovation
Dustin Plantholt appointed Chief Growth Officer Chris Kurtenbach appointed Chief Operating Officer (Jonathan) Del Lockett appointed Chief Strategy Officer Jenni Guerrica appointed Chief Information Security Officer STUART, Fla., March 18, 2025...